Ezetrol (ezetimibe), the first "cholesterol absorption inhibitor" for hyperlipidemia

Health Canada just approved Ezetrol (ezetimibe), the first "cholesterol absorption inhibitor" for hyperlipidemia.

It's marketed as Zetia in the U.S.

Ezetrol works in the gut wall to prevent cholesterol absorption through the intestinal villi.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote